RecruitingNot Applicable

Improving Nighttime Access to Care and Treatment; Part 4-Haiti

Haiti7,124 participantsStarted 2022-09-27

Plain-language summary

Children in resource-limited settings who develop illness at night are often isolated from care, resulting in progression to an emergency. A telemedicine and medication delivery service (TMDS) is a viable healthcare delivery option to bridge the gap in nighttime care. This interrupted time series study (pre/post) will evaluate a digital clinical decision-support (dCDS) tool. The objective is to assess if the tool is associated with an improvement in guideline adherence by TMDS providers.

Who can participate

Age range10 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria for child, parent/guardian participants: * Children 10 years of age or younger with an acute illness * Parent/guardian contacts the TMDS in regards to the illness during hours of operation * Parental/guardian agreement to a waiver of documentation of consent when contact is by phone only OR written consent/assent at the household from the parent/guardian and child (7yrs and older) for participants who receive a household visit. Exclusion criteria for child, parent/guardian participants: * No consent

What they're measuring

Change in provider guideline adherence rates at the call center between use of the paper and digital clinical decision support tools (CDS).

Timeframe: Two 16 month intervention periods less the 2 week wash out.

Trial details

NCT IDNCT05480930

SponsorUniversity of Florida

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2027-08

Contact for this trial

Molly B Klarman, MPH

509 4600-7486 mklarman@ufl.edu

View on ClinicalTrials.gov More Telemedicine trials